HLA-DRA and cancer: Moreover, upregulation of CXCL13 and CXCL14 are associated with a reduction in HLA-DRA and MHC-Class II, because of which cancer-specific antigens are not presented by dendritic cells and hence cancer cells evade immunosurveillance [52].